# Trade Mark Journal No.2026/003 16 January 2026

## WO0000001893869 (5)

Office of origin: Republic of Korea

Date of International Registration:21 November 2025
Date of designation in the UK: 21 November 2025

International priority date claimed: 9 June 2025 (Republic of Korea) (4020250098418)

Class 5
  Pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of inflammatory diseases; monoclonal antibodies for medical purposes; medicines for human purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of hidradenitis suppurativa.

CELLTRION, INC.

Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA